A company still losing money with shrinking sales, with elevated risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
From UPB's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $3.2M, up 16% from the 12 months before.
Move the sliders to your own view of UPB. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 100% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: profitable every year, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 12.7% to their holdings. 102 bought, 56 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
700 shares at $5.49 · $4K
2,095 shares at $5.49 · $12K
895 shares at $5.49 · $5K
485 shares at $5.49 · $3K
853 shares at $5.49 · $5K
477 shares at $6.10 · $3K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page